Stock Events

Stock Events

Xilio Therapeutics (XLO) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.25

-0.22

-0.2

-0.18

Details

Expected EPS

-0.1927

Actual EPS

-0.18

Surprise EPS

0.01

Surprise Percent

+6.59%

Description

Xilio Therapeutics (XLO) has reported earnings of -0.18 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.